Shinohara R, Mano T, Nagasaka A, Sawai Y, Uchimura K, Hayashi R, Hayakawa N, Nagata M, Makino M, Kakizawa H, Itoh Y, Nakai A, Itoh M
Department of Biochemistry, Fujita Health University School of Hygiene, Toyoake, Aichi 470-1192, Japan.
Biochim Biophys Acta. 1998 Nov 27;1425(3):577-86. doi: 10.1016/s0304-4165(98)00111-1.
Sorbitol accumulation plays an important role in diabetic complications involving the kidney, nerves, retina, lens and cardiac muscle. To investigate the influence of thyroid hormone on the sorbitol pathway, we studied the effects of thyroid hormone on polyol metabolism in normal and diabetic rats. Rats were divided into three groups: controls, streptozotocin (STZ)-induced diabetic euthyroid rats (DM) and STZ-induced diabetic hyperthyroid (thyroxine-injected) rats (DM+HT). The sorbitol (Sor) concentrations in the kidney, liver and sciatic nerve (2.53+/-0.74, 0.97+/-0.16 and 24.0+/-5.1 nmol/mg protein, respectively) of the DM rats were significantly higher than those (1.48+/-0.31, 0.58+/-0.13 and 3. 1+/-0.6 nmol/mg protein) of the control rats. The Sor concentrations in the kidney and sciatic nerve of the DM+HT rats (1.26+/-0.29 and 9. 40+/-1.2 nmol/mg protein) were significantly lower than those in the DM rats. These values were reduced in the liver, unchanged in the kidney, and increased in the sciatic nerve from the hyperthyroid rats without diabetes. Thyroid hormone reduced the aldose reductase (AR) activities in the kidney, liver and sciatic nerve of the DM rats, and similarly reduced AR in the kidney and liver, but not in the sciatic nerve, of the non-diabetic rats. The sorbitol dehydrogenase (SDH) activities were decreased by thyroid hormone in the kidney and liver but not the sciatic nerve of DM rats. In the non-diabetic rats, this enzyme activity was decreased in liver, but not in kidney or sciatic nerve. A positive correlation between the Sor concentration and AR activity was observed in the kidney and liver but not in the sciatic nerve from control, DM and DM+HT rats. A negative correlation was observed between the Sor concentration and SDH activities in the same organs. These data suggest that thyroid hormone affects the sorbitol pathway, but the detailed mechanism whereby this hormone reduces the sorbitol content (especially in diabetic rats) remains to be clarified.
山梨醇蓄积在涉及肾脏、神经、视网膜、晶状体和心肌的糖尿病并发症中起重要作用。为了研究甲状腺激素对山梨醇途径的影响,我们研究了甲状腺激素对正常和糖尿病大鼠多元醇代谢的作用。大鼠被分为三组:对照组、链脲佐菌素(STZ)诱导的糖尿病甲状腺功能正常大鼠(DM)和STZ诱导的糖尿病甲状腺功能亢进(注射甲状腺素)大鼠(DM+HT)。DM大鼠肾脏、肝脏和坐骨神经中的山梨醇(Sor)浓度(分别为2.53±0.74、0.97±0.16和24.0±5.1 nmol/mg蛋白质)显著高于对照组大鼠(1.48±0.31、0.58±0.13和3.1±0.6 nmol/mg蛋白质)。DM+HT大鼠肾脏和坐骨神经中的Sor浓度(1.26±0.29和9.40±1.2 nmol/mg蛋白质)显著低于DM大鼠。这些值在无糖尿病的甲状腺功能亢进大鼠的肝脏中降低,在肾脏中未改变,在坐骨神经中升高。甲状腺激素降低了DM大鼠肾脏、肝脏和坐骨神经中的醛糖还原酶(AR)活性,同样降低了非糖尿病大鼠肾脏和肝脏中的AR活性,但未降低坐骨神经中的AR活性。甲状腺激素降低了DM大鼠肾脏和肝脏中山梨醇脱氢酶(SDH)的活性,但未降低坐骨神经中的活性。在非糖尿病大鼠中,该酶活性在肝脏中降低,但在肾脏或坐骨神经中未降低。在对照组、DM和DM+HT大鼠的肾脏和肝脏中观察到Sor浓度与AR活性之间呈正相关,但在坐骨神经中未观察到。在相同器官中观察到Sor浓度与SDH活性之间呈负相关。这些数据表明甲状腺激素影响山梨醇途径,但该激素降低山梨醇含量(尤其是在糖尿病大鼠中)的详细机制仍有待阐明。